06/16/2025
7:06 AM | Milestone Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/14/2025
6:00 AM | Milestone Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/14/2025
6:11 AM | Milestone Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/30/2025
4:01 PM | Milestone Pharmaceuticals (Filer)
| Form DEF 14A | |
04/30/2025
4:02 PM | Milestone Pharmaceuticals (Filer)
| Form DEFA14A | |
04/22/2025
8:32 AM | BlackRock, Inc. (Filed by)
Milestone Pharmaceuticals (Subject)
| Form SCHEDULE 13G/A | |
03/28/2025
6:05 AM | Milestone Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/18/2025
4:04 PM | Milestone Pharmaceuticals (Filer)
| Form 424B5 | |
03/13/2025
6:28 AM | Milestone Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/13/2025
6:04 AM | Milestone Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/13/2025
6:18 AM | Milestone Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Get the Latest News and Ratings for MIST and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Milestone Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. |
02/14/2025
8:00 AM | Milestone Pharmaceuticals (Subject)
RTW INVESTMENTS, LP (Filed by)
| Form SCHEDULE 13G/A | |
01/29/2025
3:15 PM | Milestone Pharmaceuticals (Issuer)
Oliveto Joseph (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/29/2025
3:15 PM | Bharucha David (Reporting)
Milestone Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/29/2025
3:15 PM | Milestone Pharmaceuticals (Issuer)
Muller Lorenz (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/29/2025
3:15 PM | Hasija Amit (Reporting)
Milestone Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/29/2025
3:15 PM | Milestone Pharmaceuticals (Issuer)
Nelson Jeffrey Edward (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/24/2024
11:15 PM | Milestone Pharmaceuticals (Filer)
| Form EFFECT | |
11/12/2024
6:02 AM | Milestone Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/29/2024
3:30 PM | INTEGRATED CORE STRATEGIES LLC (0001319244) (Filed by)
Milestone Pharmaceuticals (Subject)
| Form SC 13G/A | |
09/05/2024
3:30 PM | Milestone Pharmaceuticals (Issuer)
PAPA JOSEPH C (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
09/05/2024
3:31 PM | Milestone Pharmaceuticals (Issuer)
PAPA JOSEPH C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/04/2024
7:07 AM | Milestone Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/29/2024
3:15 PM | Milestone Pharmaceuticals (Issuer)
Wills Robert James (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/29/2024
3:15 PM | Milestone Pharmaceuticals (Issuer)
TOMSICEK MICHAEL JOHN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/29/2024
3:15 PM | Fischer Seth H. Z. (Reporting)
Milestone Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/29/2024
3:15 PM | Giles Lisa M. (Reporting)
Milestone Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/29/2024
3:15 PM | Duty Stuart (Reporting)
Milestone Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/29/2024
3:15 PM | Milestone Pharmaceuticals (Issuer)
Saik Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/08/2024
3:28 PM | Milestone Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/17/2024
3:16 PM | Milestone Pharmaceuticals (Issuer)
Saik Andrew (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/17/2024
3:17 PM | Milestone Pharmaceuticals (Issuer)
Saik Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/16/2024
5:06 PM | Alta Fundamental Advisers LLC (Filed by)
Milestone Pharmaceuticals (Subject)
| Form SC 13D/A | |
07/15/2024
3:38 PM | Milestone Pharmaceuticals (Filer)
| Form DEFA14A | |
07/15/2024
3:41 PM | Milestone Pharmaceuticals (Filer)
| Form ARS | |
07/15/2024
3:34 PM | Milestone Pharmaceuticals (Filer)
| Form DEF 14A | |
07/15/2024
3:36 PM | Milestone Pharmaceuticals (Filer)
| Form DEFA14A | |
Free MIST Stock Alerts